Inist Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 146

Employees

  • Latest Deal Type
  • M&A

Inist General Information

Description

Developer of pharmaceutical drugs intended to improve the existing quality of medical treatment. The company develops multiple first generic ingredients and drugs such as alcohol detoxification medicine, dementia medicine and calcium blockade anti-cancer drugs, thereby enabling people of all age groups to enjoy a safe and healthy lifestyle.

Contact Information

Website
inistst.co.kr
Formerly Known As
Dongwoo Pharm, Dongwoo Syntech, Dongwoo Shintech, Dongwoo Pharmaceutical, Kyungsung Pharmaceutical, Chosun New Drug
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 19F Higgs U-Tower, Knowledge Industry Center
  • 184 Jungbu-daero Giheung-gu
  • Yongin-si, Gyeonggi-do
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Vivozon
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 19F Higgs U-Tower, Knowledge Industry Center
  • 184 Jungbu-daero Giheung-gu
  • Yongin-si, Gyeonggi-do
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inist Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Sep-2020 Completed Generating Revenue
3. Later Stage VC 26-Dec-2019 Completed Generating Revenue
2. Later Stage VC 01-Jan-2016 $8.47M $9.4M Completed Generating Revenue
1. Corporate 01-Jan-2015 $905K $905K Completed Generating Revenue
To view Inist’s complete valuation and funding history, request access »

Inist Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • Pending

  • Expiring in next 12 mo

Inist Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024253265-A1 Cocrystal solid comprising chromane-substituted benzimidazole derivative and zinc chloride, and method for preparing same Inactive 09-Jun-2023
WO-2024185939-A1 Chromane-substituted benzimidazole derivative and co-amorphous solid comprising inorganic salt as co-former Inactive 09-Mar-2023
WO-2022139457-A1 Bee venom injection composition comprising 50-99% of bvpla2 from bee venom extract, and preparation method therefor Inactive 24-Dec-2020
WO-2022139453-A1 Method for preparing, from bee venom extract, bee venom composition containing bvpla2 as active ingredient in amount of 50-99% Inactive 24-Dec-2020
JP-2022528748-A A composition for the prevention or treatment of neuroinflammation diseases containing bee venom extract as an active ingredient. Active 28-Mar-2019 A61K35/64
To view Inist’s complete patent history, request access »

Inist Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inist Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
AJU IB Investment Venture Capital Minority
Industrial Bank of Korea PE/Buyout Minority
TS Investment Venture Capital Minority
To view Inist’s complete investors history, request access »

Ready to get started?

Request a free trial

Inist FAQs

  • When was Inist founded?

    Inist was founded in 2000.

  • Where is Inist headquartered?

    Inist is headquartered in Yongin-si, South Korea.

  • What is the size of Inist?

    Inist has 146 total employees.

  • What industry is Inist in?

    Inist’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Inist a private or public company?

    Inist is a Private company.

  • What is Inist’s current revenue?

    The current revenue for Inist is .

  • How much funding has Inist raised over time?

    Inist has raised $9.4M.

  • Who are Inist’s investors?

    AJU IB Investment, Industrial Bank of Korea, and TS Investment have invested in Inist.

  • When was Inist acquired?

    Inist was acquired on 28-Sep-2020.

  • Who acquired Inist?

    Inist was acquired by Vivozon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process